About
In 40% of people with cardiovascular disease, the first symptom of the disease is death. ISCHEM has created a patented product permitting clinicians and healthcare facilities to determine who is acutely “vulnerable” to heart attack and stroke. ISCHEM’s product provides the means, for the first time, to noninvasively and unambiguously identify (and concurrently localize) a threatening cardiovascular problem before it unexpectedly kills or debilitates.